UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 625

Sortiert nach

Randomized Double-Blind Placebo-Controlled Trial of Bevacizumab Therapy for Radiation Necrosis of the Central Nervous System

International journal of radiation oncology, biology, physics, 2011-04, Vol.79 (5), p.1487-1495

2011

Volltextzugriff (PDF)

Effect of bevacizumab on radiation necrosis of the brain

International journal of radiation oncology, biology, physics, 2007-02, Vol.67 (2), p.323-326

2007

Volltextzugriff (PDF)

How far will the Voyager ® take us?

CNS oncology, 2019-03, Vol.8 (1), p.CNS26

Levin, Victor A

2019

Volltextzugriff (PDF)

Clinical importance of eflornithine (α-difluoromethylornithine) for the treatment of malignant gliomas

CNS oncology, 2018-04, Vol.7 (2), p.CNS16

2018

Volltextzugriff (PDF)

Malignant gliomas: MR imaging spectrum of radiation therapy- and chemotherapy-induced necrosis of the brain after treatment

Radiology, 2000-11, Vol.217 (2), p.377

2000

Volltextzugriff (PDF)

Long-term Anti-inflammatory and Antihistamine Medication Use and Adult Glioma Risk

Cancer epidemiology, biomarkers & prevention, 2008-05, Vol.17 (5), p.1277-1281

2008

Volltextzugriff (PDF)

Drug discovery in neuro-oncology: challenges in the path forward

Neuro-oncology (Charlottesville, Va.), 2018-03, Vol.20 (4), p.435-436

Levin, Victor A

2018

Volltextzugriff (PDF)

Randomized, double-blind, placebo-controlled trial of marimastat in glioblastoma multiforme patients following surgery and irradiation

Journal of neuro-oncology, 2006-07, Vol.78 (3), p.295-302

2006

Volltextzugriff (PDF)

Radiographic Response Assessment Strategies for Early-Phase Brain Trials in Complex Tumor Types and Drug Combinations: from Digital “Flipbooks” to Control Systems Theory

Neurotherapeutics, 2022-10, Vol.19 (6), p.1855-1868

2022

Volltextzugriff (PDF)

Getting More Out of Survival Data by Using the Hazard Function

Clinical cancer research, 2014-03, Vol.20 (6), p.1404-1409

2014

Volltextzugriff (PDF)

Effect of angiotensin system inhibitors on survival in newly diagnosed glioma patients and recurrent glioblastoma patients receiving chemotherapy and/or bevacizumab

Journal of neuro-oncology, 2017-09, Vol.134 (2), p.325-330

2017

Volltextzugriff (PDF)

Effect of eflornithine on mutation frequency in temozolomide-treated U87MG cells

Oncotarget, 2020-11, Vol.11 (44), p.3933-3942

2020

Volltextzugriff (PDF)

Understanding brain penetrance of anticancer drugs

Neuro-oncology (Charlottesville, Va.), 2018-04, Vol.20 (5), p.589-596

2018

Volltextzugriff (PDF)

Protein and phosphoprotein levels in glioma and adenocarcinoma cell lines grown in normoxia and hypoxia in monolayer and three-dimensional cultures

Proteome science, 2012-01, Vol.10 (1), p.5-5

2012

Volltextzugriff (PDF)

Phase III Randomized Study of Postradiotherapy Chemotherapy with Combination α-Difluoromethylornithine-PCV versus PCV for Anaplastic Gliomas

Clinical cancer research, 2003-03, Vol.9 (3), p.981-990

2003

Volltextzugriff (PDF)

Phase II Study of Fenretinide (NSC 374551) in Adults With Recurrent Malignant Gliomas: A North American Brain Tumor Consortium Study

Journal of clinical oncology, 2004-11, Vol.22 (21), p.4282-4289

2004

Volltextzugriff (PDF)

Basis and importance of Src as a target in cancer

Cancer treatment and research, 2004, Vol.119, p.89

Levin, Victor A

2004

Volltextzugriff (PDF)

Role of bevacizumab therapy in the management of glioblastoma

Cancer management and research, 2010-04, Vol.2 (default), p.97-104

2010

Volltextzugriff (PDF)

Treating anaplastic oligodendrogliomas and WHO grade 2 gliomas: PCV or temozolomide? The case for PCV

Oncology (Williston Park, N.Y.), 2015-04, Vol.29 (4), p.264, 266-264

Levin, Victor A

2015

Volltextzugriff (PDF)

Glutathione S-Transferase Polymorphisms and Survival in Primary Malignant Glioma

Clinical cancer research, 2004-04, Vol.10 (8), p.2618-2625

2004

Volltextzugriff (PDF)

Personalized medicine in neuro-oncology

CNS oncology, 2016, Vol.5 (2), p.55-58

Levin, Victor A

2016

Volltextzugriff (PDF)

Impact of bevacizumab administered dose on overall survival of patients with progressive glioblastoma

Journal of neuro-oncology, 2015-03, Vol.122 (1), p.145-150

2015

Volltextzugriff (PDF)

Modulation of Glioma Risk and Progression by Dietary Nutrients and Antiinflammatory Agents

Nutrition and cancer, 2011-02, Vol.63 (2), p.174-184

2011

Volltextzugriff (PDF)

Different Changes in Protein and Phosphoprotein Levels Result from Serum Starvation of High-Grade Glioma and Adenocarcinoma Cell Lines

Journal of proteome research, 2010-01, Vol.9 (1), p.179-191

2010

Volltextzugriff (PDF)

Phase I/II study of sorafenib in combination with temsirolimus for recurrent glioblastoma or gliosarcoma: North American Brain Tumor Consortium study 05-02

Neuro-oncology (Charlottesville, Va.), 2012-12, Vol.14 (12), p.1511-1518

2012

Volltextzugriff (PDF)

1 – 25 von 625

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(547)
Mit Volltextzugriff
(517)

Publikationsform

3 weitere anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(372)
Life Sciences & Biomedicine
(324)
Humans
(285)
Male
(148)
Female
(145)
Biological And Medical Sciences
(142)
Medical Sciences
(135)
Oncology
(133)
Adult
(123)
Middle Aged
(121)
Aged
(91)
Brain Neoplasms - Drug Therapy
(79)
Neurosciences & Neurology
(79)
Clinical Neurology
(71)
Neurology
(67)
Adolescent
(64)
Animals
(58)
Pharmacology. Drug Treatments
(52)
Chemotherapy
(51)
Tumors Of The Nervous System. Phacomatoses
(51)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

International Journal Of Radiation Oncology, Biology, Physics
(32)
Journal Of Neurosurgery
(25)
Journal Of Neuro-Oncology
(20)
Neurosurgery
(19)
Cancer Research
(18)
Neuro-Oncology
(15)
Cancer
(14)
Journal Of Clinical Oncology
(13)
Alzheimer's & Dementia
(11)
Clinical Cancer Research
(11)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

Randomized Double-Blind Placebo-Controlled Trial of Bevacizumab Therapy for Radiation Necrosis of the Central Nervous System

Effect of bevacizumab on radiation necrosis of the brain

How far will the Voyager ® take us?

Clinical importance of eflornithine (α-difluoromethylornithine) for the treatment of malignant gliomas

Malignant gliomas: MR imaging spectrum of radiation therapy- and chemotherapy-induced necrosis of the brain after treatment

Long-term Anti-inflammatory and Antihistamine Medication Use and Adult Glioma Risk

Drug discovery in neuro-oncology: challenges in the path forward

Randomized, double-blind, placebo-controlled trial of marimastat in glioblastoma multiforme patients following surgery and irradiation

Radiographic Response Assessment Strategies for Early-Phase Brain Trials in Complex Tumor Types and Drug Combinations: from Digital “Flipbooks” to Control Systems Theory

Getting More Out of Survival Data by Using the Hazard Function

Effect of angiotensin system inhibitors on survival in newly diagnosed glioma patients and recurrent glioblastoma patients receiving chemotherapy and/or bevacizumab

Effect of eflornithine on mutation frequency in temozolomide-treated U87MG cells

Understanding brain penetrance of anticancer drugs

Protein and phosphoprotein levels in glioma and adenocarcinoma cell lines grown in normoxia and hypoxia in monolayer and three-dimensional cultures

Phase III Randomized Study of Postradiotherapy Chemotherapy with Combination α-Difluoromethylornithine-PCV versus PCV for Anaplastic Gliomas

Phase II Study of Fenretinide (NSC 374551) in Adults With Recurrent Malignant Gliomas: A North American Brain Tumor Consortium Study

Basis and importance of Src as a target in cancer

Role of bevacizumab therapy in the management of glioblastoma

Treating anaplastic oligodendrogliomas and WHO grade 2 gliomas: PCV or temozolomide? The case for PCV

Glutathione S-Transferase Polymorphisms and Survival in Primary Malignant Glioma

Personalized medicine in neuro-oncology

Impact of bevacizumab administered dose on overall survival of patients with progressive glioblastoma

Modulation of Glioma Risk and Progression by Dietary Nutrients and Antiinflammatory Agents

Different Changes in Protein and Phosphoprotein Levels Result from Serum Starvation of High-Grade Glioma and Adenocarcinoma Cell Lines

Phase I/II study of sorafenib in combination with temsirolimus for recurrent glioblastoma or gliosarcoma: North American Brain Tumor Consortium study 05-02

Suchergebnisse filtern